Hennion & Walsh Asset Management, Inc. Agenus Inc Transaction History

Hennion & Walsh Asset Management, Inc.

  • $2.06 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024
BUY
$0.53 - $0.93 $7,210 - $12,651
13,604 Added 2.5%
558,606 $323,000
Q4 2023

Jan 10, 2024
BUY
$0.63 - $1.14 $23,977 - $43,388
38,060 Added 7.51%
545,002 $452,000
Q3 2023

Oct 27, 2023
BUY
$1.12 - $1.88 $268,151 - $450,111
239,421 Added 89.5%
506,942 $572,000
Q2 2023

Aug 09, 2023
BUY
$1.31 - $2.04 $350,452 - $545,742
267,521 New
267,521 $428,000

Others Institutions Holding AGEN

# of Institutions
8
Shares Held
2.07M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Hennion & Walsh Asset Management, Inc. Portfolio

Follow Hennion & Walsh Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email